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Introduction
Oral cell carcinoma belongs to the group of human 
head and neck cancers which causes high morbidity and 
mortality. In the year 2012 alone globally the oral cancers 
were estimated to have a fresh incidence and mortality 
of 300,373 and 145,353 respectively. The estimated 
prevalence for the year 2015 was 324,398 cases of 
incidence and 157,139 cases of deaths due to oral cancer 
(Ferlay et al., 2013; Forman et al., 2014). India has the 
highest incidences of oral cancer, 20 per every 100,000 
population and it accounts for 30% of all cancers in this 
country (More and D’Cruz, 2013). The most common 
form of oral cancer is the squamous cell carcinoma which 
accounts for about 90% of all oral cancers (Ferlay et al., 
2013; Krishna et al., 2013). 
Many key risk factors have been identified for the 
susceptibility to oral cancer such as use of tobacco, 
consumption of alcohol, infection with human papilloma 
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Abstract
 Imperata cylindrica, a tall tufted grass which has multiple pharmacological applications is one of the key 
ingredients in various traditional medicinal formula used in India. Previous reports have shown that I. cylindrica 
plant extract inhibited cell proliferation and induced apoptosis in various cancer cell lines. To our knowledge, no 
studies have been published on the effect of I. cylindrica leaf extract on human oral cancers. The present study 
was undertaken in order to evaluate the anticancer properties of the leaf extract of I. cylindrica using an oral 
squamous cell carcinoma cell line SCC-9 as an in vitro model system. A methanol extract from dried leaves of I. 
cylindrica (ICL) was prepared by standard procedures.  Effects of the ICL extract on the morphology of SCC-9 
cells was visualized by microscopy.  Cytotoxicity was determined by MTT assay. Effects of the ICL extract on 
colony forming ability of SCC-9 cells was evaluated using clonogenic assay. Cell cycle analysis was performed 
by flow cytometry and induction of apoptosis was determined by DNA fragmentation assay. The ICL extract 
treatment caused cytotoxicity and induced cell death in vitro in SCC-9 cells in a dose-dependent manner. This 
treatment also significantly reduced the clonogenic potential and inhibited cell proliferation by arresting the 
cell cycle in the G2/M phase. Furthermore, DNA fragmentation assays showed that the observed cell death was 
caused by apoptosis. This is the first report showing the anticancer activity of the methanol extracts from the 
leaves of I. cylindrica in human oral cancer cell line. Our data indicates that ICL extract could be considered 
as one of the lead compounds for the formulation of anticancer therapeutic agents to treat/manage human oral 
cancers.  The natural abundance of I. cylindrica and its wide geographic distribution could render it one of the 
primary resource materials for preparation of anticancer therapeutic agents.  
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virus (HPV), malnutrition, vitamin deficiency and, poor 
dental and oral hygiene. In addition, the incidence of 
oral cancer is further increased due to the high usage of 
chewable/smokeless tobacco and betel quid in India (de 
Camargo Cancela et al., 2010; IARC, 2012; Anantharaman 
et al., 2013; Krishna et al., 2013). Data from the National 
Cancer Registry in India shows a gender based difference 
in oral cancer incidence with a men:women ratio of 2:1 
which is suggestive of lifestyle and behavioral differences 
among genders (Sankaranarayanan et al., 2005; Thorat et 
al., 2009). 
In developed countries the highest incidence of oral 
cancer was found in individuals who belong to the age 
group of 55 to 64 years. However, in the Southeast Asian 
countries, especially in India, Sri Lanka, Pakistan and 
Bangladesh, the affected individuals were below 40 years 
of age and it was attributed mainly to the higher rate of 
tobacco usage (More and D’Cruz, 2013). During the 
years 2001 to 2003 the age-specific oral cancer mortality 
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rate in India for individuals between the age of 30 to 69 
years was 22.9%, which is twice as much as compared 
to the mortality rate of 11.4% for lung cancer (Dikshit et 
al., 2012). 
Even though the conventional cancer treatments 
such as surgery, chemotherapy and radiation therapy 
are beneficial to some extent, often times they also exert 
severe, toxic side effects that affect patients’ quality of life 
post treatments (Qi et al., 2010). In addition, emergence 
of resistant cancer cells post therapeutic interventions has 
prompted a critical need for the development of alternative 
approaches to treat/manage these cancers (Saraswathy 
and Gong, 2013). In this regard use of phytochemical 
agents have emerged as a lead alternative as they possess 
proven effective anticancer activity with minimal/no 
adverse side effects (Fulda, 2010). Several compounds 
such as vinca alkaloids, taxanes, camptothecin etc., with 
effective anticancer activity have been purified from 
many natural resources. Notably, more than 60% of all 
approved new anticancer drugs within the past decade 
are of phytochemical origin (Newman and Cragg, 2007; 
Fulda, 2010). 
The grass, Imperata cylindrica (L.) Raeusch. 
(Poaceace), is known as Thatch grass or Cogon grass in 
English and Darbh in Hindi in India (Jayalakshmi et al 
2010; Parvathy et al., 2012). It is a perennial, erect, tall 
tufted grass and it has a wide distribution throughout the 
Indian subcontinent, tropics and sub tropics of Africa, 
South-East Asia and Australia (Jayalakshmi et al, 2010; 
Parvathy et al, 2012). I. cylindrica has been known to 
have several medicinal applications as mentioned in 
the Ayurvedic Pharmacopoeia of India, 2006. In Indian 
traditional medicine, it is known to be used as a diuretic 
and an anti-inflammatory agent (Khare, 2007). Its 
diuretic properties have been reported by Doan et al., 
1992 and Shah et al., 2012. In addition, it is reported to 
possess immunomodulatory (Pinilla and Luu, 1999) as 
well as neuroprotective (Yoon et al., 2006) activities. I. 
cylindrica is one of the important herbs used in ayurvedic 
formulations possessing significant antioxidant activities 
(Sushama and Nishteswar, 2014; Pragya et.al., 2015). A 
study conducted on an ayurvedic formulation consisting 
of I. cylindrica as one of the constituents has shown a 
possible potential as an adjuvant in cancer radiotherapy 
to produce beneficial results (Guruprasad et al., 2010).
Previous reports have shown that I. cylindrica plant 
extract inhibited cell proliferation and induced apoptosis 
in various cancer cell lines (Kuete et al., 2011; Kuete 
et al., 2013). To our knowledge, so far, no studies have 
been published on the effect of I. cylindrica leaf extract 
on human oral cancers. Therefore, the present study was 
undertaken in order to evaluate the anticancer properties of 
the leaf extract of I. cylindrica (ICL) using an established 
oral squamous cell carcinoma cell line SCC-9 as an in 
vitro model system.
Materials and Methods
Materials and reagents
Tris-HCl, NaCl, EDTA, SDS, Triton X-100, dimethyl 
sulfoxide (DMSO), formaldehyde and, DNase free-
RNase-A were purchased from Merck Co. Mumbai, 
India. Propidium iodide (PI) was obtained from Beckton 
Dickinson, Gurgaon, Haryana, India. Dulbecco’s 
Modified Eagles Medium (DMEM), fetal bovine serum 
(FBS), penicillin-streptomycin and trypsin-EDTA were 
purchased from Gibco BRL (Life technologies, Grand 
Island, NY, USA). 3-(4, 5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide (MTT) reagent was 
obtained from Sisco Research Laboratories Pvt. Ltd., 
Mumbai, India. Crystal violet and proteinase K were 
obtained from Hi-Media, Mumbai, India. Hind III digest 
λ DNA (catalogue number D-4521) was obtained from 
Sigma -Aldrich, St. Louis, MO, USA.
Plant material collection and preparation of methanol 
extracts 
The Imperata cylindrica plant was collected from 
areas around Hassan township, Hassan district in the 
state of Karnataka, India. The herbarium specimen 
was authenticated at the botanical garden, University 
of Agricultural Sciences, G.K.V.K campus, Bangalore, 
Karnataka, India. A voucher specimen (Collection number 
- RKDSKPDF01; accession number - UASB3843) has 
been deposited at the herbarium. Freshly procured I. 
cylindrica leaves were surface sterilized with 70% ethanol, 
air dried in shade and pulverized using a commercial 
waring blender. Methanol extract was prepared by treating 
10 g of leaf powder with 100 ml methanol (100%) in 
soxhlet apparatus (Vasa Scientific Co., Bangalore, India) 
at 60ºC for 8h (Harborne, 1998). The crude extracts 
were filtered using Whatman No.1 filter paper (Merck 
Co. Mumbai, India.) and concentrated using a rotary 
evaporator (Rotavapor R-100, BUCHI India Pvt. Ltd., 
Mumbai, India).Stock solution was prepared by dissolving 
the dried residue in appropriate volume of 100% dimethyl 
sulfoxide (DMSO) to get a final concentration of 64mg/
ml, from which required dilutions were prepared.
Cell lines and culture conditions
Human tongue squamous cell carcinoma, SCC-9 
(ATCC CRL-1629), and NIH/3T3 (ATCC CRL-1658) 
mouse embryonic fibroblast cell lines were obtained from 
American Type Culture Collection (ATCC, Manassas, VA, 
USA) and maintained as recommended by the supplier. 
The SCC-9 and NIH/3T3 cells were grown in DMEM 
medium supplemented with 2.5 mM L-glutamine, 15 mM 
HEPES, and 10% FBS, along with 100 U/ml penicillin and 
100 µg/ml streptomycin. These cells were maintained at 
37ºC in a humidified incubator under 95% air atmosphere 
plus 5% CO2. 
Treatment with ICL extract
All the experiments were done in triplicate in order to 
obtain statistically significant data. The ICL extracts were 
diluted with culture medium to give serial concentrations 
prior to application to the cells. The control cells were 
treated with media containing 1% DMSO. 
Morphological assessment of SCC-9 cells treated with 
ICL extract
The effect of ICL extract on SCC-9 cell morphology 
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were assessed by light microscopy. The SCC-9 cells were 
seeded at a density of 5 × 104 cells/well in a 96-well cell 
culture plate and treated with various concentrations of 0 
to 640 μg/ml of the ICL extract for 24 h. NIH/3T3 mouse 
embryo fibroblast cells were used as an additional control. 
Changes in the cell morphology, if any, between the 
control and the ICL extract treated cells were monitored 
using a light microscope (Magnus 11D475, New Delhi, 
India) and documented by photography.
Cytotoxicity analysis by MTT assay
The SCC-9 cells and NIH/3T3 cells were seeded in a 
sterile flat bottom 96 -well plate at a density of 5 × 104 cells 
per well and incubated for 24 h in the culture conditions 
described were section 2.3 of Materials and Methods. 
Twenty four hours post seeding these cells were treated 
with ICL extracts to final concentrations of 10, 20, 40, 80, 
160, 320 and 640 µg/ml. The control cells were treated 
with media containing 1% DMSO. Twenty four hour 
post treatment with ICL extracts the culture media were 
replaced with 100 µl of MTT reagent at a concentration 
of 0.5 mg/ml and incubated for 4 h at 37ºC in dark. Then 
the MTT reagent was removed and the formazan crystals 
when present were solubilized in 100 µl of DMSO 
with gentle shaking and incubated for an additional 15 
minutes at room temperature in dark (Mosmann, 1983). 
The absorbance of the ICL extract treated samples and 
the control vehicle treated samples from each well was 
measured at 590 nm using a microtiter plate reader 
(TECAN Spectra Fluor plus, MTX Lab Systems, Inc., 
VA, U.S.A.). The cytotoxicity was calculated according 
to the protocol supplied by the manufacturer and it was 
expressed as percentage of growth inhibition in the ICL 
treated cells as compared to the vehicle treated control 
cells. The percentage growth inhibition was calculated 
using the following formula: 
Percentage inhibition of cell proliferation=[(Absorbance 
of vehicle treated control group-Absorbance of ICL treated 
experimental group) / (Absorbance of vehicle treated 
control group)] x 100. 
Estimation of ICL treated and vehicle treated SCC-9 cells 
at various stages of cell cycle
Approximately 1×106 SCC-9 cells were cultured in a 
6-well plate containing 2 ml of complete DMEM plus 10% 
FBS and incubated as described section 2.3 of Materials 
and Methods. Approximately 32 h later the media was 
replaced with DMEM containing 1% serum and incubated 
for an additional 32 h in order to synchronise the cell cycle 
by serum starvation (Chen et al., 2012). After the cell cycle 
synchronisation, a final concentration of 80, 160, 320 and 
640 µg/ml of ICL extracts were added to the cells and the 
control cells were left untreated. Twenty four hour post 
exposure to ICL extract, the untreated control and treated 
cells were washed twice with 1x PBS and fixed with 
prechilled 70% ethanol for 24 h at 4º C. These cells were 
again washed twice with 1x PBS, incubated with 100 µg/
ml of DNase free-RNase-A at 37ºC for 1h and stained for 
30 minutes with 50 µg/ml of propidium iodide in 0.1% 
Trition X-100 plus 0.1 mM EDTA at room temperature 
(Nair et al., 2014). The cells were then analyzed for cell 
cycle distribution using BD FACS Calibur flow cytometer 
(Becton Dickinson, San Jose, CA, USA). The relative 
proportions of cells at the various phases of the cell cycle 
were estimated based on their DNA contents and it was 
calculated using an inbuilt CellQuest Pro software.
Clonogenic assay
Clonogenic assay was performed as described 
previously (Franken et al., 2006). The SCC-9 cells were 
harvested by trypsinization from a 70 to 80% confluent 
monolayer, washed and resuspended in DMEM medium. 
These cells were seeded at a density of 5 x 103 cells per 35 
mm dish containing DMEM with 10 % FBS, and incubated 
at 37ºC in a humidified incubator for 24 h. The cells were 
then treated either with 80, 160, 320, and 640 µg/ml of 
ICL extract or with 1% DMSO vehicle and incubated for 
an additional 24 h. At the end of the incubation period the 
media was replaced with fresh DMEM containing 10 % 
FBS, and the medium was renewed once in every 5 days. 
After 21 days, the media was removed and the cells were 
washed with 1x PBS, fixed with 3.7 % paraformaldehyde 
in 1x PBS, and stained with 0.25% crystal violet for 30 
min at room temperature. The colonies of cells were 
washed in 1x PBS to remove excess dye and air dried. The 
number of colonies containing at least 50 cells / colony 
was counted using a Stereomicroscope (Motic, Hong 
Kong) to determine the plating efficiency (PE). The ratio 
of PE between treated and untreated cells represented 
the surviving fractions (SF) of colony forming cells. The 
clonogenic ability of the untreated control cells were taken 
as 100%. The data were collected from three independent 
experiments and the mean ± SD were calculated.
DNA fragmentation assay
The SCC-9 cells were seeded in cell culture plates and 
treated with 320 and 640 µg/ml ICL extracts for 24 h at 
37ºC in a humidified atmosphere of 5% CO2 as described 
in section 2.3 of Materials and Methods. The untreated 
control and the treated cells were collected and lysed 
with 1.0 ml of lysis buffer and treated with DNase free-
RNase-A (50 µg/ml) in the presence of 0.1% SDS for 1h at 
37°C. The lysis buffer consisted of 100 mM NaCl, 10 mM 
Tris-HCl (pH 8.0), 25 mM EDTA, 0.5% sodium dodecyl 
sulphate (SDS) and 200 µg/ml of DNase-free proteinase K. 
The DNAs were precipitated with 100% ethanol, washed 
and resuspended in TE (Tris-Hcl-EDTA) buffer (Mitra et 
al., 2012). Three micrograms of the DNAs from control 
and treated samples were separated electrophoretically in 
a 1.2 % agarose gel containing 0.001% ethidium bromide. 
The bands were visualized and photographed using a gel 
documentation system (Syngene, Cambridge, UK).
Statistical analyses
Data for MTT, clonogenicity and cell cycle were 
expressed as mean ± standard deviation (SD). Nonlinear 
regression analysis was employed to obtain dose-response 
curve on a logarithmic scale and to determine relative 
IC50 value. The statistical comparison to determine 
significant differences between treated and control group 
was performed by one-way or two-way ANOVA followed 
by Dunnett’s post-hoc test. All statistical analysis was 
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performed using Graph Pad Prism (Graph Pad Software 
Inc. San Diego, USA). The differences between the 
control and treated groups were considered significant 
when p<0.05.
Results 
Effect of ICL extract treatment on the morphology of 
SCC-9 cells
The control untreated SCC-9 cells showed epithelial 
like morphological characteristics (Figure 1, left panel). 
The ICL treated SCC-9 cells showed significant changes 
visually as they lost the characteristic epithelial-like 
morphology. The treated cells also lost contact with 
adjacent cells, considerably shrank in size and attained 
rounded shape (Figure 1, center and right panel). The 
morphological changes were well pronounced when the 
cells were exposed to ICL extracts at the concentrations 
of 320 and 640 µg/ml. No significant change in the 
morphology was found when these cells were treated 
with lower concentrations of ICL extracts. The NIH/3T3 
cells which were used as an additional control showed 
little morphological changes when treated with high 
concentrations of ICL extracts (data not shown).
Cytotoxic effect of ICL extract on SCC-9 cells
The relative IC50 of the ICL extract was found to be 
139.8 µg/ml (Figure 2A). The MTT assay revealed a dose 
dependent inhibition of SCC-9 cell proliferation when 
these cells were treated with various concentrations of 
ICL extracts for 24 h (Figure 2B). Treatment with lower 
concentrations of 10 to 40 µg/ml of ICL extracts resulted 
in less than 20% inhibition of SCC-9 cell proliferation. 
Moderate concentrations of 80 and 120 µg/ml of the 
ICL extract caused only a 20 to 25% of inhibition of 
cell proliferation. At the concentrations of 320 µg/ml 
and 640 µg/ml the ICL extract inhibited SCC-9 cell 
proliferation by approximately 50% and 60% respectively. 
No such inhibition of cell proliferation was found when 
the NIH/3T3 cells were treated with the same higher 
concentrations of ICL extracts (Figure 2C). The observed 
cytotoxicity of the ICL extract was specific only to the 
oral squamous cell carcinoma cell, SCC-9, and not to the 
control NIH/3T3 fibroblast cells (Figure 2A, 2B, 2C).
Effect of ICL extract on clonogenic potential of SCC-9 
cells
Higher proportion of Surviving Fractions (SFs) of 
0.8 and 0.7 were observed when the SCC-9 cells were 
treated for 24 h with moderate concentrations of 80 µg/
Figure 1. Morphology of SCC-9 Cells Upon Treatment 
with ICL Extract. Morphological features of the cells 
were visualized using light microscope and photographed at 
10X magnification. The left panel shows control cells with an 
epithelial-like morphology typical of SCC-9 cells. The centre and 
right panel show cells after 24 h treatment with 320 and 640 µg/
ml ICL extract respectively. Pronounced morphological changes 
- loss of contact with adjacent cells, considerable shrinkage in 
size and rounded shape can be observed
Control 320 640 
ICL extract (µg/ml) 
Figure 2. Cytotoxicity of ICL Extract on Human 
Tongue Squamous Cell Carcinoma (SCC-9) and 
Fibroblast Cells (NIH/3T3) Determined by MTT Assay. 
(A) Dose-dependent growth inhibitory effect were observed in 
ICL extract treated SCC-9 cell line with an IC50 of 139.8µg/ml. 
Inhibitory effect was not observed in the control (1% DMSO 
vehicle) cells. (B) The bars represent percent growth inhibition 
of SCC-9 cells ± SD of triplicate experiments. When compared 
to the control the results were statistically significant (*p<0.05, 
**p<0.005, ***p<0.0008). (C) The bars represent percent growth 
inhibition of NIH/3T3 cells ± SD of triplicate experiments. No 
significant growth inhibition was observed
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Figure 3. Effect of ICL Extract on Clonogenic Ability 
of SCC-9 Cells. (A) Survival curve with mean values ± SD 
are presented. (B) Quantitative bar-graph representing the 
number of colonies (> 50 cells / colony) as percentage relative 
to the untreated control, mean ± SD from three independent 
experiments. When compared to the control the results were 
statistically significant (*p<0.05, **p<0.005)
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ml and 160 µg/ml of ICL extracts respectively. However, 
significantly reduced number of SFs of 0.5 and 0.15 
were found when these cells were treated with higher 
concentrations of 320 μg/ml and 640 µg/ml of ICL extracts 
respectively (Figure 3A). The untreated, control SCC-9 
cells had the maximum clonogenic ability of 100%. The 
clonogenic ability was found to be more than 90% when 
these cells were treated with a moderate concentration 
of 80 µg/ml of ICL extract. Approximately 70% of the 
SCC-9 cells retained their clonogenic ability after the 
treatment with a moderate concentration of 160 µg/ml. 
At higher concentrations of 320 µg/ml and 640 µg/ml 
the clonogenic ability was significantly reduced to 50% 
and 15% respectively (Figure 3B). The reduced SFs and 
clonogenecity in the ICL extract treated SCC-9 cells as 
compared to the untreated control cells were statistically 
significant with a value of **p<0.001.
Effect of ICL extract on the SCC-9 cell cycle
A small percentage of 10.1% of the total number of 
the untreated control SCC-9 cells were found in the G2/M 
phase of the cell cycle. However after 24 h of treatment 
with 320 µg/ml and 640 µg/ml of ICL extracts a higher 
fraction of 18.91% and 27.20% were found in G2/M phase 
respectively (Figure 4A). Simultaneously, the percentage 
of total fraction of cells at the G0/G1 phase decreased to 
72.14 and 61.09% when they were treated with 320 µg/
ml and 640 µg/ml respectively. However the untreated 
control had more than 80% cells in G0/G1 phase (Figure 
4B, 4C). The differences observed in the number of cells 
at the G0/G1 and G2/M phases in the treated SCC-9 cells 
as compared to the untreated control cells were statistically 
significant with a ***p<0.0001. 
Effect of ICL extract treatment on the DNA integrity and 
DNA laddering
A large proportion of the DNA samples from the 
untreated control SCC-9 cells barely entered the agarose 
gel and there was no DNA fragmentation in the form of 
a ladder in these control samples. However, almost all 
of the DNA samples from the cells treated for 24 h with 
320 µg/ml or 640 µg/ml of ICL extracts freely entered 
the gel. The DNA samples from these treated cells also 
showed apoptosis specific DNA ladder and the size of 
the bands in these ladders ranged from 200 to 1,800 base 
pairs (Figure 5).
Discussion
Phytocompounds are emerging as one of the promising 
alternative therapeutics for treatment and management 
of human cancers because of the systemic toxicity 
caused by the existing therapeutic agents as well as the 
emergence of treatment resistant cancer cells. Extracts of 
I. cylindrica have diverse pharmacological activities and 
more importantly they have no side effects or systemic 
toxicity in humans. Oral administration of this formulation 
to patients caused no harm or side effects such as burning 
sensation to the digestive system or diarrhea (Jayalakshmi 
et al, 2010; Parvathy et al, 2012).
Many anticancer drugs extracted from medicinal 
plants exert their cytotoxic effects through a common 
mechanism. In general, these phyto compounds seem to 
invariably induce cell cycle arrest and cause cell death 
by apoptosis (Xavier et al., 2009; Tsai et al., 2012). 
Likewise, the extracts from I. cylindrica also inhibited 
cell proliferation and induced apoptosis in various human 
cancer cell lines (Kuete et al., 2011; Kuete et al., 2013).
Figure 4. Flow Cytometric Analysis of ICL Extract 
Treated SCC-9 Cells at Various Stages of the Cell 
Cycle. (A) Left panel - untreated control; Middle panel- 320 µg/
ml ICL extract treated cells; Right panel - 640 µg/ml ICL extract 
treated cells. (B) The percentage of cells in phases of the cell 
cycle in both treated and control as indicated. The results are the 
mean ± SD of data from three independent experiments. When 
compared to control the results were statistically significant 
(***p<0.0001). (C) Table showing the percentage of cells in 
the different phases of the cell cycle in treated and control 
SCC-9 cells
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Figure 5. DNA Fragmentation Assay. Lane 1, DNA from 
the untreated control SCC-9 cells; Lane 2, DNA from SCC-9 
cells treated with 320 µg/ml of ICL extract; Lane 3, DNA from 
SCC-9 cells treated with 640 µg/ml of ICL extract; Lane 4, 0.5 
µg of lambda DNA Hind III digest; Lane 5, 0.2 µg of lambda 
DNA, Hind III digest. The arrows indicate the bands in the DNA 
ladder. The molecular weights are marked on the right
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Phytoderivatives from cranberry and grape 
seed extracts as well as a plant derived compound, 
proanthocyanidin caused morphological changes in oral 
squamous cell carcinoma (King et al., 2007; Chatelain 
et al., 2011). Data from the present study show similar 
morphological changes in the ICL extract treated SCC-9 
squamous cell carcinoma cell line. It is important to note 
that these changes were found only when these cells were 
treated with higher concentrations of the extract which is 
indicative of concentration dependent effect of ICL extract 
on SCC-9 cells (Figure 1). MTT assay was performed 
to assess the cytotoxic potential of ICL extracts, as only 
mitochondrial dehydrogenase formed in viable cells are 
able to reduce tetrazolium salt (MTT) into an insoluble 
formazan product (Mosmann, 1983). Data from the MTT 
assay further confirms the cytotoxicity and also supports 
the concentration dependent cytotoxic effect of ICL extract 
on SCC-9 cells (Figure 2A, 2B). The observed cytotoxic 
effect of ICL extract only to the SCC-9 squamous cell 
carcinoma cells and not to the NIH/3T3 normal fibroblast 
cells indicates that the cytotoxicity is restricted only to 
the cancer cells and not to the normal cells (Figure 2C). 
Our data on the cancer cell specific cytotoxicity of ICL 
extract is in agreement with the previous reports which 
have demonstrated cytotoxicity of I. cylindrica extract in 
vitro on other cancer cell lines (Kuete et al., 2011; Kuete 
et al., 2013).
Clonogenecity is one of the important characteristics 
of cancer cells. The clonogenic assay is one of the 
standard methods for measuring the anti-clonogenic 
effect of cytotoxic agents in vitro (Katz et al., 2008).
It is widely recognized that any substance that inhibits 
clonogenic progression of tumor cells could be considered 
as a potential anticancer therapeutic agent (Katz et al., 
2008; Rafehi et al., 2011). Therefore, the effect of ICL 
extract on the colony formation ability was assessed by 
clonogenic assay. Our data from the clonogenic survival 
assay show that the exposure of SCC-9 cells to higher 
concentrations of ICL extract significantly inhibited the 
clonogenic potential of these cells in vitro (Figure 3A, 3B). 
The observed anti-clonogenic activity of the ICL extract 
is indicative of its potential use as anticancer therapeutic 
agent especially to treat/manage human oral cancers. 
Many anticancer agents arrest cancer cell division 
at various stages of the cell cycle. Genistein, a natural 
isoflavinoid caused cell cycle arrest in MCF-7 human 
breast cancer cell line in vitro in a dose dependent manner. 
At higher concentrations genistein caused persistent 
cell cycle arrest at G2/M phase (Pagliacci et al., 1994). 
Another plant product “Ruta” showed anticancer activity 
against colon cancer cell line COLO 205 and it caused 
cell death and cell cycle arrest at G2/M phase (Arora and 
Tandon, 2015). The cytotoxic and anti-clonogenic effects 
of ICL extracts on SCC-9 cells were further examined by 
evaluating the cell cycle distribution post treatment.Data 
from the present study showed that the ICL extracts from 
the plantI. cylindrica caused cell death and cell cycle arrest 
at G2/M phase (Figure 4A, 4B, 4C).
Integrity of DNA is a prerequisite for the survival and 
for the maintenance of infinite proliferative potential of 
cancer cells and many phytocompounds with anticancer 
property disrupt this integrity (Tsai et al., 2012; Arora and 
Tandon, 2015). Presence of a characteristic DNA ladder 
in the cancer cells post anticancer treatment is a hallmark 
of apoptotic cell death (Wyllie, 1980; Hengartner, 2000). 
Presence of such a DNA ladder in the ICL extract treated 
SCC-9 cells as compared to the untreated control cells 
indicates that the observed cell death was caused by 
apoptosis (Figure5).
The change in morphology, cytotoxicity, anti-
clonogenic activity, cell cycle arrest and DNA 
fragmentation observed in the ICL extract treated SCC-
9 squamous cell carcinoma cells as compared to the 
untreated control show that these effects were caused by 
the ICL extract treatment. The characteristic cell cycle 
arrest at G2/M and the DNA fragmentation caused by 
ICL extract indicates that the cell death was caused by 
apoptosis and not by generalized cellular toxicity. It is 
important to note that the ICL extract induced cell death 
only at higher concentrations and further purification 
and fractionation could yield active compounds that are 
effective at lower doses.
Thus, the ICL extract obtained from I. cylindrica can 
be developed into a potential anticancer therapeutic agent 
to manage/treat human oral cancers. Biochemical analysis 
of the roots of I. cylindrica indicated the presence of 
glycosides, alkaloids and flavonoids (Amin et al., 2009). 
Our preliminary biochemical analysis show the presence 
of similar compounds in the I. cylindrica leaf extract as 
well (data not shown). It would be interesting to evaluate 
if these constituents either individually or in various 
combinations and concentrations could act in synergy to 
produce anticancer activity. 
In conclusion, This is the first report revealing the 
anticancer activity of the methanol extracts from the 
leaves of I. cylindrica on oral cancer cell lines. The 
anticancer activity of the ICL extract was specific for the 
human tongue squamous cell carcinoma, SCC-9, cells 
and not to the NIH/3T3 fibroblast cells. It is important 
to note that the ICL extract caused cell death in SCC-9 
cancer cells by reducing their clonogenecity, generating 
DNA fragmentation and by inducing apoptosis. Abundant 
quantities of I. cylindrica grow in the wild in many parts 
of the world and they can also be easily cultivated in any 
muddy ground space around the scientific laboratories 
as they demand little care. Currently, cancer research 
is concentrated towards combinatorial therapies where 
multiple units of the cancer cell survival pathways could 
be disrupted simultaneously. Such strategies would help 
to reduce cancer recurrence or even completely eliminate 
all cancer cells; thereby improve the quality of life of 
the cancer patients post anticancer treatment regimen. 
In this regard the present study opens up a new avenue 
towards development of novel, cost effective, anticancer 
therapeutic agent from an abundant plant source, I. 
cylindrica, whose products already have been proven to 
have no undesirable side effects or systemic toxicity in 
human. Overall data from the present study opens up novel 
perspectives and pharmacological avenues as a promising 
modality for effective treatment and management of 
human oral cancers. 
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